Aegerion agreed to pay $36 million to the feds in a Juxtapid marketing case, but a federal judge thought that wasn't good enough. Tuesday, he sentenced the company to pay the same total—only this time, patients got a chunk of the settlement.Original Article
Judge that nixed Juxtapid’s DOJ settlement prompts Aegerion to admit its off-label sins
